Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumor markers. Their current diagnostic status].

S Kudlacek1

  • 1Institut für angewandte und experimentelle Onkologie, Wien.

Wiener Medizinische Wochenschrift (1946)
|May 31, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cathepsin S controls adipocytic and osteoblastic differentiation, bone turnover, and bone microarchitecture.

Bone·2014
Same author

The bone marker plot: an innovative method to assess bone turnover in women.

European journal of clinical investigation·2009
Same author

Serum levels of receptor activator of nuclear factor kappaB ligand (RANKL) in healthy women and men.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2007
Same author

Calcium supply, bone mineral density and genetically defined lactose maldigestion in a cohort of elderly men.

Journal of endocrinological investigation·2007
Same author

Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer.

European journal of clinical investigation·2006
Same author

Immunology and aging.

The aging male : the official journal of the International Society for the Study of the Aging Male·2006
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Post-pandemic rebound of rotavirus and adenovirus in pediatric gastroenteritis: a 6-year antigen-based surveillance study from Turkey.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Neuroaxis involvement in Chikungunya virus infection: a retrospective case series.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

A complicated case of a spinal Scedosporium apiospermum infection with a favorable outcome-case report.

Wiener medizinische Wochenschrift (1946)·2026
See all related articles

Researchers are developing better tumor markers for cancer diagnosis and monitoring. Monoclonal antibodies offer enhanced specificity for detecting cancer markers, improving early detection and treatment strategies.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Context:

  • Tumor markers are crucial for cancer diagnosis, but current markers often lack specificity and ideal characteristics.
  • Widespread clinical use of some markers has occurred despite limitations, highlighting the need for improved diagnostic tools.

Purpose:

  • To review the characteristics of an ideal tumor marker and the potential of monoclonal antibodies in improving cancer detection.
  • To explore the application of monoclonal antibodies in identifying novel tumor markers and enhancing diagnostic specificity.

Summary:

  • The ideal tumor marker should be tumor-specific, detectable in body fluids, absent in healthy individuals, reflect disease burden, and correlate with therapy response.
  • Monoclonal antibodies offer superior specificity compared to conventional antibodies, enabling precise detection of tumor-specific antigens.

Related Experiment Videos

  • Techniques like immunofluorescence, immunoperoxidase labeling, and radiolabeled antibodies are being utilized for tumor identification and localization.

    • Impact:

    • Monoclonal antibodies hold promise for expanding the range of available diagnostic tests and improving the specificity of cancer marker detection.
    • Identifying tumor-specific molecules, potentially through monoclonal antibody technology, could lead to earlier cancer diagnosis and more effective patient monitoring.
    • Continued advancements in tumor-associated markers are essential for improving cancer treatment and diagnostic approaches.